Last Updated:
Name Designation Appointment Date Status
Neelam Khatri

Appointed as Director since August 2014

 Director 01-Aug-2014 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for D.D.Khatri Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Ashok Khatri

Appointed as Director since September 2013

 Director 11-Sep-2013 Current
Dharmender Chawla

Appointed as Director since September 2025

 Director 27-Sep-2025 Current
Ankur Pahuja

Appointed as Director since September 2013

 Director 11-Sep-2013 Current

People Timeline

Explore the timeline of key personnel in D.D.Khatri Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address Qu-82B, First Floor Near Income Tax Colony, Pitampura, New Delhi Delhi, 110088, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110088
  • Country India
  • Website -
Frequently Asked Questions
You can contact D.D.Khatri Pharmaceuticals Private Limited through their registered address at Qu-82B, First Floor Near Income Tax Colony, Pitampura, New Delhi Delhi, 110088, India, or via their website if available. Social media links are also provided where applicable.
The current directors of D.D.Khatri Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • NEELAM KHATRI
  • ASHOK KHATRI
  • DHARMENDER CHAWLA
  • ANKUR PAHUJA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available